Early-stage pulmonary adenocarcinoma (T1N0M0): A clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience

Modern Pathology

Volumn 26, Issue 8, 2013, Pages 1065-1075

  Weissferdt, Annikka ^a   Kalhor, Neda ^a   Marom, Edith M ^a   Benveniste, Marcelo F ^a   Godoy, Myrna C ^a   Correa, Arlene M ^a   Swisher, Stephen G ^a   Moran, Cesar A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenocarcinoma in situ; Bronchioloalveolar carcinoma; Pulmonary adenocarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATIONAL STUDY; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84881311968     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.33     Document Type: Article

References (44)

1. Travis WD, Brambilla E, Mü ller-Hermelink K, et al. Tumours of the lung, pleura, thymus, and heart, In: Pathology & Genetics, World Health Organization. IARC Press: Lyon, France; 2004, pp 38.
2. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285.
3. Moran CA. Importance of molecular features of nonsmall cell lung cancer for choice of treatment. Am J Pathol 2011;178:1940-1948.
4. Overholt RH, Meissner WA, Delmonico E. Favorable bronchiolar carcinoma. Chest 1955;27:403-413.
5. Watson I, Farppour A. Terminal bronchiolar or 'alveolar cell' cancer of the lung: Two hundred sixty-five cases. Cancer 1966;19:776-780.
6. Belgrad R, Good A, Woolner LB. Alveolar-cell carcinoma (Terminal Bronchiolar Carcinoma): A study of surgically excised tumors with special emphasis on localized lesions. Radiology 1962;79:789-798.
7. Munell ER, Lawson RC, Keller DF. Solitary bronchiolar (alveolar cell) carcinoma of the lung. J Thorac Cardiovasc Surg 1966;52:261-270.
8. Marco M, Galy P. Bronchioloalveolar carcinoma: Clinicopathologic relationships, natural history, and prognosis in 29 cases. Am Rev Resp Dis 1973;107: 621-629.
9. Schraunagel D, Peloquin A, Pare JAP, et al. Differentiating bronchioloalveolar carcinoma from adenocarcinoma. Am Rev Respir Dis 1982;125:74-79.
10. Singh G, Katyal SL. Bronchioloalveolar carcinomas: A heterogenous group. Am Rev Resp Dis 1982;125:183.
11. Singh G, Katyal SL, Torikata C. Carcinoma of type II pneumocytes: Immunodiagnosis of a subtype of 'bronchioloalveolar carcinomas.'. Am J Pathol 1981; 102:195-208.
12. Dermer GB. Origin of bronchioloalveolar carcinoma and peripheral bronchial adenocarcinoma. Cancer 1982;49:881-887.
13. Manning JT, Spjut HJ, Tsechen JA. Bronchioloalveolar carcinoma: The significance of two histopathologic types. Cancer 1984;54:525-534.
14. Clayton F. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates. Cancer 1986;57:1555-1564.
15. Daly RC, Trastek VF, Pairolero PC, et al. Bronchoalveolar carcinoma: Factors affecting survival. Ann Thorac Surg 1991;51:368-377.
16. Feldman ER, Eagan RT, Schaid DJ. Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: Comparison of clinical manifestations, chemotherapeutic responses, and prognosis. Mayo Clin Proc 1992;67:27-32.
17. Breathnach OS, Ishibe N, Williams J, et al. Clinical features of patients with stage IIIb and IV bronchioloalveolar carcinoma of the lung. Cancer 1999;86: 1165-1173.
18. Hsu CP, Chen CY, Hsu NY. Bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995;110:374-381.
19. Fujimoto N, Segawa Y, Takigawa N, et al. Clinical investigation of bronchioloalveolar carcinoma: A retrospective analysis of 53 patients in a single institution. Anticancer Res 1999;19:1369-1374.
20. Liebow AA. Bronchiolo-alveolar carcinoma. Adv Int Med 1960;10:329-358.
21. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: The clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 2006;1:S13-S19.
22. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: Histologic characteristics and prognosis. Cancer 1995;75:2844-2852.
23. Zell JA, Ou SHI, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: Improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 2005;23:8396-8405.
24. Zell JA, Ou SHI, Ziogas A, et al. Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revision for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry. J Thorac Oncol 2007;2:1078-1085.
25. Sidhu SG, Wieczorek R, Cassai ND, et al. The concept of bronchioloalveolar cell adenocarcinoma: Redefinition, a critique of the 1999 WHO classification, and an ultrastructural analysis of 155 cases. Int J Surg Pathol 2003;11:89-99.
26. Hajdu SI. A note from history: The story of bronchioloalveolar carcinoma. Annals of Clinical & Laboratory Science 2005;35:336-338.
27. Breathnach OS, Kwiatowski DJ, Finkelstein DM, et al. Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg 2001;121:42-47.
28. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg 2002;74:1640-1647.
29. Yamamoto Y, Tsuchida M, Watanabe T, et al. Early resection of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg 2001;71:971-974.
30. Watanabe S, Watanabe T, Arai K, et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground glass attenuation on computed tomography. Ann Thorac Surg 2002;73: 1071-1075.
31. Suzuki K, Asamura H, Kusumoto M, et al. 'Early' peripheral lung cancer: Prognostic significance of ground glass opacity on thin-section computed tomography scan. Ann Thorac Surg 2002;74:1635-1639.
32. Sakurai H, Dobashi Y, Mizutani E, et al. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: A retrospective assessment. Ann Thorac Surg 2004;78:1728-1733.
33. Yamada S, Kohno T. Video-assisted thoracic surgery for pure ground glass opacities 2 cm or less in diameter. Ann Thorac Surg 2004;77:1911-1915.
34. Yoshida J, Nagai K, Yokose T, et al. Limited resection trial for pulmonary ground glass opacity nodules: Fifty case experience. J Thorac Cardiovasc Surg 2004;129:991-996.
35. Koike T, Togashi K, Shirato T, et al. Limited resection for non-invasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg 2009;88:1106-1111.
36. Vasques M, Carter D, Brambilla E, et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: Histopathologic features and their prognostic implications. Lung Cancer 2009;64: 148-154.
37. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24: 653-664.
38. Sakurai H, Dobashi Y, Mizutani E, et al. Bronchioloalveolar carcinoma of the lung 3 centimeters of less in diameter: A prognostic assessment. Ann Thorac Surg 2004;78:1728-1733.
39. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinomas of the lung. Am J Surg Pathol 2004;28:198-206.
40. Yim J, Zhu LC, Chiriboga L, et al. Histological features are important prognostic indicators in early stages lung adenocarcinoma. Mod Pathol 2007;20:233-241.
41. Borczuk AC, Qian F, Kazeros A, et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 2009;33:462-469.
42. Kadota K, Suzuki K, Kachala SS, et al. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol 2012;25:1117-1127.
43. Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg 1998;116: 276-280.
44. Konaka C, Ikeda N, Hiyoshi T, et al. Peripheral nonsmall lung cancers 2.0 cm or less in diameter: Proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer 1998;21:185-191.